Abstract
Antileishmanial activity and organ distribution of the antifungal drug Amphotericin-B in free and liposomised form have been studied in Balb/c mice infected withLeishmania donovani. Results indicate that Amphotericin-B in the liposomised form is significantly more active than the free form. This increase in the activity is perhaps related to the reduced drug toxicity rather than the altered drug distribution at the site of infection.
Similar content being viewed by others
Abbreviations
- Amp-B:
-
Amphotericin-B
- Chol:
-
cholesterol
- SPC:
-
soya phosphatidylcholine
- EPC:
-
egg phosphatidylcholine
- HPLC:
-
high pressure liquid chromatography
References
Ahmad I, Sarkar A K and Bachhawat B K 1989 Liposomal Amphotericin-B in the control of experimental aspergillosis in mice: Part I—Relative therapeutic efficacy of free and liposomal Amphotericin-B;Indian J. Biochem. Biophys. 26 351–356
Ahmad I, Sarkar A K and Bachhawat B K 1990 Effect of cholesterol in various liposomal compositions on thein vivo toxicity, therapeutic efficacy, and tissue distribution of Amphotericin-B;Biotechnol. Appl. Biochem. 12 550–556
Alving C R 1986 Liposomes as drug carriers in leishmaniasis and malaria;Parasitol. Today 2 101–107
Berman J D, Hanson W L, Chapman W L, Alving C R and Lopez-Berestein G 1986 Antileishmania activity of liposome-encapsulated Amphotericin-B in hamsters and monkeys;Antimicrob. Agents Chemother. 30 847–851
Graybill J R, Craven C P, Taylor R L, Williams D M and Magee W E 1982 Treatment of murine cryptococcaris with liposome associated Amphotericin-B;J. Infect. Dis. 145 748–752
Graybill J R and Craven C P 1983 Antifungal agents used in systemic mycoses: activity and therapeutic use;Drugs 25 41–62
Gupta C M and Bali A 1981 Carbamyl analogs of phosphatidylcholines: synthesis, interaction with phospholipases and permeability behaviour of their liposomes;Biochim. Biophys. Acta 663 506–515
Lopez-Berestein G, Mehta R, Hopfer R L, Mills K, Kasi L, Mehta K, Fainstein V, Luna M, Hersh E M and Juliano R 1983 Treatment and prophylaxis of disseminated infection due toCandida albicans in mice with liposome-encapsulated Amphotericin-B;J. Infect. Dis. 147 939–945
Lopez-Berestein G, Rosenblum M G and Mehta R 1984 Altered tissue distribution of Amphotericin-B by liposomal encapsulation: Comparison of normal mice to mice infected withCandida albicans;Cancer Drug Deliv. 1 199–205
Mehta R, Lopez-Berestein G, Hopfer R, Mills K and Juliano R 1984 Liposomal Amphotericin-B is toxic to fungal cells but not to mammalian cells;Biochim. Biophys. Acta 770 230–234
New R R C, Chance M L and Heath S 1981 Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes;J. Antimicrob. Chemother. 8 371–381
Trembaly C, Barga M, Fiore C and Szoka F 1984 Efficacy of liposome-intercalated Amphotericin-B in the treatment of systemic candidiasis in mice;Antimicrob. Agents Chemother. 26 170–173
Wasan K M, Vadiei K, Lopez-Berestein G and Luke D R 1990 Pharmacokinetics, tissue distribution, and toxicity of free and liposomal Amphotericin-B in diabetic rats;J. Infect. Dis. 161 562–566
Author information
Authors and Affiliations
Additional information
CDRI communication No. 4789
Rights and permissions
About this article
Cite this article
Ahmad, I., Agarwal, A., Pal, A. et al. Tissue distribution and antileishmanial activity of liposomised Amphotericin-B in Balb/c mice§ . J Biosci 16, 217–221 (1991). https://doi.org/10.1007/BF02703287
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02703287